SCHEMBL7983209

SCHEMBL7983209

Cc1cccc(Cl)c1-c1ncc2c(N)nc3ccc(NCCCN4CCOCC4)cc3n12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.58
FGFR1 P11362 6/20 0.47
SRC P12931 3/20 0.47
FGFR2 P21802 1/20 0.46
FGFR4 P22455 1/20 0.46
FGFR3 P22607 1/20 0.46
KDR P35968 1/20 0.46
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PDE2A O00408 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
RAD52 P43351 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983648 0.95 LCK (0.57) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7980015 0.93 LCK (0.52) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7983613 0.88 LCK (0.51) LCKFGFR1SRCALDH1A1HSD17B10
SCHEMBL7983672 0.85 FGFR1 (0.53) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7983879 0.85 FGFR1 (0.55) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7984551 0.83 FGFR1 (0.48) LCKFGFR1SRCALDH1A1KDM4E
SCHEMBL4041225 0.83 FGFR1 (0.51) LCKFGFR1SRCKDRALDH1A1
SCHEMBL7983062 0.82 LCK (0.50) LCKFGFR1KDRPDE2A
SCHEMBL7979955 0.81 LCK (0.54) LCKFGFR1KDRPDE2A
SCHEMBL7980189 0.81 CAMK2D (0.44) LCKFGFR1KDRRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed